temocillin has been researched along with cefotaxime in 14 studies
| Studies (temocillin) | Trials (temocillin) | Recent Studies (post-2010) (temocillin) | Studies (cefotaxime) | Trials (cefotaxime) | Recent Studies (post-2010) (cefotaxime) |
|---|---|---|---|---|---|
| 216 | 17 | 78 | 5,747 | 727 | 790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Docquier, JD; Frère, JM; Rossolini, GM; Stoczko, M | 1 |
| De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Azadian, BS; Talboys, C; Waghorn, DJ | 1 |
| Verbist, L | 1 |
| Cooper, CE; Griffin, KE; Slocombe, B; White, AR | 1 |
| Malottke, R; Potel, J | 1 |
| Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W | 1 |
| Edmondson, RA; Reading, C | 1 |
| Boelaert, J; Piot, P; Van Landuyt, HW; Verbist, L | 1 |
| Bartmann, K; Tarbuc, R | 1 |
| Ferreiro, C; Hainaut, M; Levy, J; Nogarède, C; Piepsz, A; Tondeur, M | 1 |
| Athlin, S; Bergström, J; Edlund, C; Edquist, P; Giske, CG; Hanberger, H; Månsson, E; Östholm Balkhed, Å; Skoog Ståhlgren, G; Tempé, M; Ternhag, A | 1 |
| Edlund, C; Larsson, S; Nauclér, P; Svensson, M; Ternhag, A | 1 |
1 trial(s) available for temocillin and cefotaxime
| Article | Year |
|---|---|
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Female; Gastrointestinal Microbiome; Humans; Male; Penicillins; Sweden; Urinary Tract Infections | 2022 |
13 other study(ies) available for temocillin and cefotaxime
| Article | Year |
|---|---|
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Molecular Sequence Data; Open Reading Frames; Pectobacterium carotovorum; Phenotype; Phylogeny; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cefuroxime; Clavulanic Acids; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Spectinomycin | 1986 |
Temocillin sensitivity of Enterobacteriaceae species resistant to cefotaxime.
Topics: Cefotaxime; Enterobacteriaceae; In Vitro Techniques; Penicillin Resistance; Penicillins | 1985 |
Temocillin. In vitro antibacterial activity.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cefuroxime; Dose-Response Relationship, Drug; Drug Interactions; Enterobacteriaceae; In Vitro Techniques; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1985 |
Antibacterial activity of temocillin.
Topics: Cefazolin; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
Beta-lactamase stability of temocillin.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Cephamycins; Chromosomes, Bacterial; In Vitro Techniques; Penicillins; Plasmids | 1985 |
In vitro activity of temocillin against clinical isolates.
Topics: Bacteria; Cefotaxime; Cefuroxime; Cephalothin; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1985 |
In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Topics: Cefazolin; Cefotaxime; Enterobacteriaceae; Gram-Negative Bacteria; Haemophilus; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Species Specificity | 1983 |
Late renal sequelae in intravenously treated complicated urinary tract infection.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Penicillins; Pyelonephritis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Dimercaptosuccinic Acid; Treatment Outcome; Urinary Tract Infections | 2013 |
Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance.
Topics: Anti-Bacterial Agents; Cefotaxime; Cost-Benefit Analysis; Drug Resistance, Microbial; Humans; Urinary Tract Infections | 2022 |